Invention Grant
- Patent Title: Compounds for the treatment of mTOR pathway related diseases
-
Application No.: US14420081Application Date: 2013-08-05
-
Publication No.: US09790176B2Publication Date: 2017-10-17
- Inventor: Mohammad Hossein Pourgholami , David L. Morris , Roger Aston
- Applicant: Pitney Pharmaceuticals Pty Limited
- Applicant Address: AU Kogarah
- Assignee: Pitney Pharmaceuticals Pty Limited
- Current Assignee: Pitney Pharmaceuticals Pty Limited
- Current Assignee Address: AU Kogarah
- Agency: Kilpatrick Townsend & Stockton LLP
- Priority: AU2012903365 20120806
- International Application: PCT/AU2013/000859 WO 20130805
- International Announcement: WO2014/022879 WO 20140213
- Main IPC: A61K31/275
- IPC: A61K31/275 ; C07C255/00 ; C07C323/62 ; C07C317/44 ; C07C255/29 ; C07C255/62 ; A61K31/277
Abstract:
The present invention relates to compounds for the treatment of mTOR (mammalian Target Of Rapamycin) pathway related diseases. Specifically, the present invention relates to the use of aminoactonitrile derivatives (AADs) in the treatment of mTOR pathway related diseases.
Public/Granted literature
- US20150166477A1 COMPOUNDS FOR THE TREATMENT OF MTOR PATHWAY RELATED DISEASES Public/Granted day:2015-06-18
Information query
